Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases Data from a Long-Term Observation
- PMID: 28275330
- PMCID: PMC5318917
- DOI: 10.1159/000449038
Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases Data from a Long-Term Observation
Abstract
Background: Dependent on the absence or presence of associated diseases, autoimmune thrombocytopenia (ITP) can be classified as primary or secondary form. The manifestation of the associated diseases is not temporally defined and may occur during observation. Thus the question which disease is the primary one remains unanswered.
Methods: All 386 patients included in this study were treated by a single primary physician between 1996 and 2015 at the Charité Berlin and met current ITP criteria. Medical records and investigations were reviewed to assess diseases associated with ITP.
Results: Initially, the vast majority of patients presented with primary ITP (isolated disease). Based on our findings, ITP was found to be associated with other abnormalities in most cases. These abnormalities included: positive direct antiglobulin test in 49 of 386 tested patients (13%), affections of the thyroid gland in 41 of 386 tested patients (11%), infections in 30 (8%), solid malignancies in 20 (5%) and hematological malignancies in 10 patients (3%), as well as many other miscellaneous diseases. Moreover, of 160 patients who did not receive prior intravenous immunoglobulin treatment, 40 (25%) showed antibody deficiency.
Conclusion: In conclusion, the incidence of 'true' ITP as a primary disease is less common than has yet been suggested. Additionally, there is evidence that ITP itself predispose affected subjects toward development of other diseases.
Keywords: Antibody deficiency syndrome; Autoimmune thrombocytopenia; Evans syndrome; Platelets; Secondary autoimmune thrombocytopenia.
Similar articles
-
[Etiology and clinical characteristics of pregnancy-emerged thrombocytopenia].Zhonghua Fu Chan Ke Za Zhi. 2011 Nov;46(11):834-9. Zhonghua Fu Chan Ke Za Zhi. 2011. PMID: 22333233 Chinese.
-
Childhood immune thrombocytopenia: Clinical presentation and management.Sudan J Paediatr. 2012;12(1):27-39. Sudan J Paediatr. 2012. PMID: 27493327 Free PMC article. Review.
-
Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study.Eur J Haematol. 2020 Jan;104(1):55-58. doi: 10.1111/ejh.13336. Epub 2019 Oct 27. Eur J Haematol. 2020. PMID: 31594025 Free PMC article.
-
Pathogenesis of immune thrombocytopenia in common variable immunodeficiency.Autoimmun Rev. 2020 Sep;19(9):102616. doi: 10.1016/j.autrev.2020.102616. Epub 2020 Jul 17. Autoimmun Rev. 2020. PMID: 32682985 Review.
-
[Idiopathic thrombocytopenic purpura in children].Med Pregl. 1998 Mar-Apr;51(3-4):127-34. Med Pregl. 1998. PMID: 9611955 Review. Croatian.
Cited by
-
Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.Blood Adv. 2021 Mar 23;5(6):1617-1626. doi: 10.1182/bloodadvances.2020003004. Blood Adv. 2021. PMID: 33710335 Free PMC article.
-
Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches.Sci Rep. 2025 Jul 1;15(1):21211. doi: 10.1038/s41598-025-01448-7. Sci Rep. 2025. PMID: 40593806 Free PMC article.
-
A Case of Immune Thrombocytopenia as a Rare Side Effect of an Immunotherapy with PD1-Blocking Agents for Metastatic Melanoma.Transfus Med Hemother. 2017 Nov;44(6):426-428. doi: 10.1159/000479237. Epub 2017 Sep 14. Transfus Med Hemother. 2017. PMID: 29344020 Free PMC article.
-
Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.PLoS One. 2018 Jun 1;13(6):e0198184. doi: 10.1371/journal.pone.0198184. eCollection 2018. PLoS One. 2018. PMID: 29856800 Free PMC article.
-
Platelets in ITP: Victims in Charge of Their Own Fate?Cells. 2021 Nov 19;10(11):3235. doi: 10.3390/cells10113235. Cells. 2021. PMID: 34831457 Free PMC article. Review.
References
-
- Liebman HA, Stasi R. Secondary immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14:557–573. - PubMed
-
- Ruggeri M, Fortuna S, Rodeghiero F. Heterogenity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature. Haematologica. 2008;93:98–103. - PubMed
-
- Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–2393. - PubMed
-
- Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–186. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous